| 2026-08-13 | 8-K | 10.1 | Securities Purchase Agreement, dated August 11, 2026, by and between the Company and each investor party thereto |
|---|
| 2026-05-15 | 8-K | 10.2 | Form of New Warrant |
|---|
| 2026-05-15 | 8-K | 10.1 | Form of Inducement Letter |
|---|
| 2025-09-26 | 8-K | 10.1 | At the Market Offering Agreement, dated September 26, 2025, between the Company and H.C. Wainwright & Co., LLC |
|---|
| 2025-09-12 | 8-K | 10.1 | Securities Purchase Agreement, dated September 11, 2025, by and between the Company and each investor party thereto |
|---|
| 2025-08-01 | 8-K | 10.3 | Form of Placement Agent Warrant |
|---|
| 2025-08-01 | 8-K | 10.2 | Form of New Warrant |
|---|
| 2025-08-01 | 8-K | 10.1 | Form of Inducement Letter |
|---|
| 2025-03-14 | 8-K | 10.1 | Note Conversion Inducement Agreement dated March 13, 2025 |
|---|
| 2025-01-30 | 8-K | 10.3 | Form of Placement Agent Warrant |
|---|
| 2025-01-30 | 8-K | 10.2 | Form of New Warrant |
|---|
| 2025-01-30 | 8-K | 10.1 | Form of Inducement Letter |
|---|
| 2025-01-17 | 8-K | 10.1 | Securities Purchase Agreement, dated January 15, 2025, by and between the Company and each investor party thereto |
|---|
| 2025-01-15 | 8-K | 10.1 | Amendment No.1, effective January 14, 2025, to Ordinary Share Purchase Agreement, dated August 13, 2024, by and between Silexion Therapeutics Corp (formerly known as Biomotion Sciences) and White Lion Capital, LLC |
|---|
| 2024-08-21 | 8-K | 10.12 | SILEXION THERAPEUTICS CORP 2024 EQUITY INCENTIVE PLAN |
|---|
| 2024-08-21 | 8-K | 10.6 | FORM OF DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT, DATED AUGUST 15, 2024, BY AND BETWEEN SILEXION THERAPEUTICS CORP (FORMERLY KNOWN AS BIOMOTION SCIENCES) AND EACH OF ITS EXECUTIVE OFFICERS AND DIRECTORS |
|---|
| 2024-08-21 | 8-K | 10.5 | AMENDED AND RESTATED PROMISSORY NOTE, DATED AUGUST 15, 2024, ISSUED BY SILEXION THERAPEUTICS CORP (FORMERLY KNOWN AS BIOMOTION SCIENCES) TO MORINGA SPONSOR, L.P |
|---|
| 2024-08-21 | 8-K | 10.4 | AMENDED AND RESTATED REGISTRATION RIGHTS AND LOCK-UP AGREEMENT, DATED AUGUST 14, 2024 AND EFFECTIVE AS OF THE CLOSING DATE, BY AND AMONG SILEXION THERAPEUTICS CORP (FORMERLY KNOWN AS BIOMOTION SCIENCES) |
|---|
| 2024-08-21 | 8-K | 10.3.2 | REGISTRATION RIGHTS AGREEMENT, DATED AUGUST 13, 2024 AND EFFECTIVE AS OF THE CLOSING DATE OF THE BUSINESS COMBINATION, BY AND BETWEEN SILEXION THERAPEUTICS CORP (FORMERLY KNOWN AS BIOMOTION SCIENCES) AND WHITE LION CAPITAL, LLC |
|---|
| 2024-08-21 | 8-K | 10.3.1 | ORDINARY SHARE PURCHASE AGREEMENT, DATED AUGUST 13, 2024 AND EFFECTIVE AS OF THE CLOSING DATE OF THE BUSINESS COMBINATION, BY AND BETWEEN SILEXION THERAPEUTICS CORP (FORMERLY KNOWN AS BIOMOTION SCIENCES) AND WHITE LION CAPITAL, LLC |
|---|
| 2024-08-21 | 8-K | 10.2 | SUBSCRIPTION AGREEMENT, DATED AUGUST 15, 2024, BY AND AMONG MORINGA ACQUISITION CORP, SILEXION THERAPEUTICS CORP (FORMERLY KNOWN AS BIOMOTION SCIENCES) AND GREENSTAR, L.P |
|---|
| 2024-08-21 | 8-K | 10.1.2 | CONVERTIBLE PROMISSORY NOTE, DATED AUGUST 15, 2024, IN AN AMOUNT OF $1,250,000, ISSUED BY SILEXION THERAPEUTICS CORP (FORMERLY KNOWN AS BIOMOTION SCIENCES) TO EARLYBIRDCAPITAL, INC |
|---|
| 2024-08-21 | 8-K | 10.1.1 | FINAL INVOICE ISSUED BY EARLYBIRDCAPITAL, INC. TO MORINGA ACQUISITION CORP UNDER THE BUSINESS COMBINATION MARKETING AGREEMENT, DATED FEBRUARY 16, 2021, BY AND BETWEEN EARLYBIRDCAPITAL, INC. AND MORINGA ACQUISITION CORP |
|---|